Evidence map›Paper›PMID 26811286›Full record

ReviewInternational review of cell and molecular biology2016

Phosphatidylethanolamine Metabolism in Health and Disease.

Elizabeth Calzada, Ouma Onguka, Steven M Claypool

Abstract readReview
In one paragraph

Review in International review of cell and molecular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 286 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
286citing papers in PubMed, 2 pooled it
37.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

286 citing papers in PubMed, 2 syntheses or guidelines pooled it, 507 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Lipidome of Endemic FishMembranes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Fatty acid regulation and phosphatidylethanolamine biosynthesis are important for hepatitis E virus replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

226 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Elizabeth CalzadaDepartment of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ouma OngukaDepartment of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Steven M ClaypoolDepartment of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Mitochondrial phosphatidylethanolamine metabolismR01GM111548 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI CLAYPOOL, STEVEN MICHAEL · 2014 to 2021
$2.8M
NIGMS NIH HHS R01 GM111548NIGMS NIH HHS R01GM111548
6 · The paper itself

Abstract

Phosphatidylethanolamine (PE) is the second most abundant glycerophospholipid in eukaryotic cells. The existence of four only partially redundant biochemical pathways that produce PE, highlights the importance of this essential phospholipid. The CDP-ethanolamine and phosphatidylserine decarboxylase pathways occur in different subcellular compartments and are the main sources of PE in cells. Mammalian development fails upon ablation of either pathway. Once made, PE has diverse cellular functions that include serving as a precursor for phosphatidylcholine and a substrate for important posttranslational modifications, influencing membrane topology, and promoting cell and organelle membrane fusion, oxidative phosphorylation, mitochondrial biogenesis, and autophagy. The importance of PE metabolism in mammalian health has recently emerged following its association with Alzheimer's disease, Parkinson's disease, nonalcoholic liver disease, and the virulence of certain pathogenic organisms.

Indexed as

Alzheimer DiseaseAnimalsAutophagyCandidaCarboxy-LyasesCell MembraneCytidine DiphosphateEthanolaminesHumansLipid MetabolismMethylationMitochondriaNon-alcoholic Fatty Liver DiseaseOxidative PhosphorylationParkinson DiseasePhosphatidylcholinesCarboxy-LyasesCDP ethanolamineCytidine DiphosphateEthanolaminesPhosphatidylcholinesPhosphatidylethanolaminesphosphatidylserine decarboxylasePhospholipidsPrionsAlzheimer's diseaseautophagyCDP-ethanolaminemitochondriaParkinson's diseasephosphatidylethanolaminephosphatidylserine decarboxylase

Identifiers

PMID26811286
PMCPMC4778737
OpenAlexW2411561471

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.